Program Description and Accreditation Information:
- IBD IMPACT is an Accredited Self-assessment Activity (Section 3), which uses the case-based Script Concordance Test (SCT) format to allow participants to assess their knowledge, skills, and clinical judgment in the management of inflammatory bowel disease (IBD).
- Section 3 credits not to exceed 2 hours (for a total of 6 credits) per activity.
- Ask your Takeda representative for more information or click here.
- Module 1: Importance of Objectively Measuring Outcomes in Patients with UC.
- Module 2: Importance of Choosing the Right Biologic for Patients with UC.
- Module 3: Nutritional Considerations in the Management of Patients with CD.
- Module 4: Importance of Choosing the Right Biologic for Patients with CD.
- Recognize the importance of mucosal and histological healing in patients with ulcerative colitis (UC) or Crohn’s disease (CD).
- Employ patient factors and disease characteristics to help choose a biologic for patients with UC.
- Describe factors affecting nutritional status, and use evidence-based dietary strategies in the management of patients with CD.
- Employ patient factors and disease characteristics to help choose a biologic for patients with CD.
Developed in collaboration with:
- John K. Marshall, MD, MSc, FRCPC, AGAF
- Waqqas Afif, MD, MSc, FRCPC
- Brian Bressler, MD, MSc, FRCPC
- Shane Devlin, MD, FRCPC
- Cynthia Seow, MD, MBBS
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Gastroenterology (CAG). This program was co-developed with Takeda Canada and was planned to achieve scientific integrity, objectivity, and balance. This Program expires September 15th, 2024.